Chronic Thermogenic Dietary Supplement Consumption

Summary

This study is a randomized, double-blind, placebo-controlled trial. Healthy, exercising adult males and females will be recruited for participation. After providing informed consent, each participant will be randomized to one of three groups: 1) OxyShred thermogenic fat burner; 2) Placebo (PL); and 3) Control. All participants will complete a baseline laboratory visit consisting of assessments of body composition, anthropometry, metabolism, hemodynamics, dietary intake, exercise habits, and subjective variables. Participants in the two intervention groups (i.e., OxyShred and PL) will then be given dietary supplements for daily consumption, including OxyShred/PL and protein powder. Participants in all groups will complete the 4-week study and follow their usual training and nutrition habits - besides increased protein intake in the OxyShred and PL groups - along with questionnaires to assess compliance with the study protocol and potential side effects of supplementation. Following this 4-week period, participants will complete a second laboratory visit, where all baseline assessments will be repeated. The effects of group (OxyShred, PL, and control) and time (baseline, 4 weeks) will be statistically examined using linear models, along with appropriate post-hoc tests.

Conditions

• Body Composition Changes
• Body Weight Changes
• Anthropometric Changes
• Metabolism Changes
• Hemodynamic Changes

Interventions

DIETARY_SUPPLEMENT

Thermogenic dietary supplement

Daily ingestion of OxyShred thermogenic dietary supplement.

DIETARY_SUPPLEMENT

Protein supplement

Daily ingestion of protein supplement.

DIETARY_SUPPLEMENT

Placebo supplement

Daily ingestion of a placebo dietary supplement.

Sponsors & Collaborators

• EHP Labs

  collaborator UNKNOWN

• Texas Tech University

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

40 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-01-17

Primary Completion

2023-05-15

Completion

2023-05-15

Countries

• United States

Study Locations